Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The price of Oscar Health Inc (NYSE: OSCR) closed at $20.45 in the last session, down -4.62% from day before closing price of $21.44. In other words, the price has decreased by -$4.62 from its previous closing price. On the day, 15.34 million shares were traded. OSCR stock price reached its highest trading level at $22.09 during the session, while it also had its lowest trading level at $20.235.
Ratios:
We take a closer look at OSCR’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.22.
On March 13, 2025, Wells Fargo Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $20 to $16.
On December 10, 2024, Jefferies started tracking the stock assigning a Underperform rating and target price of $12.Jefferies initiated its Underperform rating on December 10, 2024, with a $12 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jun 20 ’25 when RANMALI BOPITIYA bought 30,000 shares for $18.77 per share.
ALESSANDREA QUANE bought 148,280 shares of OSCR for $2,598,488 on May 16 ’25. On May 12 ’25, another insider, Robinson Elbert O. Jr., who serves as the Director of the company, sold 25,000 shares for $16.43 each. As a result, the insider received 410,750 and left with 64,512 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OSCR now has a Market Capitalization of 5208144896 and an Enterprise Value of 2827629312. As of this moment, Oscar’s Price-to-Earnings (P/E) ratio for their current fiscal year is 73.40, and their Forward P/E ratio for the next fiscal year is 23.17. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.47. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.52 while its Price-to-Book (P/B) ratio in mrq is 3.89. Its current Enterprise Value per Revenue stands at 0.28 whereas that against EBITDA is 14.146.
Stock Price History:
The Beta on a monthly basis for OSCR is 1.90, which has changed by 0.19800818 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, OSCR has reached a high of $23.79, while it has fallen to a 52-week low of $11.20. The 50-Day Moving Average of the stock is 31.37%, while the 200-Day Moving Average is calculated to be 29.97%.
Shares Statistics:
According to the various share statistics, OSCR traded on average about 11.41M shares per day over the past 3-months and 29532240 shares per day over the past 10 days. A total of 217.98M shares are outstanding, with a floating share count of 180.17M. Insiders hold about 29.26% of the company’s shares, while institutions hold 61.45% stake in the company. Shares short for OSCR as of 1749772800 were 29748645 with a Short Ratio of 2.61, compared to 1747267200 on 19074655. Therefore, it implies a Short% of Shares Outstanding of 29748645 and a Short% of Float of 15.120000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The current market rating for Oscar Health Inc (OSCR) reflects the collective analysis of 4.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.14, with high estimates of -$0.02 and low estimates of -$0.24.
Analysts are recommending an EPS of between $0.84 and $0.59 for the fiscal current year, implying an average EPS of $0.68. EPS for the following year is $1.19, with 4.0 analysts recommending between $1.88 and $0.85.
Revenue Estimates
According to 7 analysts, the current quarter’s revenue is expected to be $2.88B. It ranges from a high estimate of $3B to a low estimate of $2.72B. As of the current estimate, Oscar Health Inc’s year-ago sales were $2.22BFor the next quarter, 7 analysts are estimating revenue of $2.76B. There is a high estimate of $2.83B for the next quarter, whereas the lowest estimate is $2.69B.
A total of 8 analysts have provided revenue estimates for OSCR’s current fiscal year. The highest revenue estimate was $11.29B, while the lowest revenue estimate was $11.05B, resulting in an average revenue estimate of $11.24B. In the same quarter a year ago, actual revenue was $9.18BBased on 8 analysts’ estimates, the company’s revenue will be $11.09B in the next fiscal year. The high estimate is $12.64B and the low estimate is $9.03B.
